Captopril and S-nitrosocaptopril as potent radiosensitizers: Comparative study and underlying mechanisms

Cancer Lett. 2010 Jul 28;293(2):213-9. doi: 10.1016/j.canlet.2010.01.016. Epub 2010 Feb 9.

Abstract

In an effort to improve the issue of radiotherapy treatments, we tested whether S-nitrosocaptopril, a molecule combining a NO donor and an angiotensin converting enzyme inhibitor (ACE inhibitor), could temporarily improve the hemodynamic status of experimental tumors. We monitored the effect of S-nitrosocaptopril in TLT tumors using non rinvasive magnetic resonance techniques. We identified a time window during which tumor oxygenation was improved, as a result of a combined effect on tumor blood flow and oxygen consumption. Consequently, the administration of S-nitrosocaptopril contributed to the increase in efficacy of radiation therapy, an effect that was not observed with captopril alone.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Animals
  • Captopril / analogs & derivatives*
  • Captopril / pharmacology*
  • Hemodynamics / drug effects*
  • Liver Neoplasms, Experimental / blood supply
  • Liver Neoplasms, Experimental / metabolism
  • Liver Neoplasms, Experimental / radiotherapy*
  • Male
  • Mice
  • Neoplasm Transplantation
  • Nitric Oxide
  • Oxygen Consumption
  • Radiation Tolerance / drug effects*
  • Vasodilator Agents / pharmacology

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Vasodilator Agents
  • S-nitrosocaptopril
  • Nitric Oxide
  • Captopril